Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice

Journal of Virology

Volumn 79, Issue 4, 2005, Pages 2115-2123

  Wang, Weijia ^a   Taylor, Shannon L ^b   Leisenfelder, Stacey A ^b   Morton, Robert ^b   Moffat, Jennifer F ^b   Smirnov, Sergey ^a   Zhu, Hua ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; LIVER; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SCID MOUSE; THYMUS; VIROGENESIS; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENES, VIRAL; GENOME, VIRAL; HUMANS; MICE; MICE, SCID; OPEN READING FRAMES; TRANSPLANTATION, HETEROLOGOUS; VIRULENCE; VIRUS REPLICATION;

ANIMALIA; BACTERIA (MICROORGANISMS); DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 13444261953     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.4.2115-2123.2005     Document Type: Article

References (44)

1. Auwaerter, P. G., H. Kaneshima, J. M. McCune, G. Wiegand, and D. E. Griffin. 1996. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol. 70:3734-3740.
2. Baldick, C. J., Jr., A. Marchini, C. E. Patterson, and T. Shenk. 1997. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J. Virol. 71:4400-4408.
3. Balfour, H. H., Jr., G. W. Sachs, P. Welo, R. C. Gehrz, R. L. Simmons, and J. S. Najarian. 1984. Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. Birth Defects Orig. Artic. Ser. 20:289-304.
4. Bidanset, D. J., R. J. Rybak, C. B. Hartline, and E. R. Kern. 2001. Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. J. Infect. Dis. 184:192-195.
5. Boehncke, W. H. 1999. The SCID-hu xenogeneic transplantation model: complex but telling. Arch. Dermatol. Res. 291:367-373.
6. Bonyhadi, M. L., and H. Kaneshima. 1997. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Mol. Med. Today 3:246-253.
7. Borst, E.-M., G. Hahn, U. H. Koszinowski, and M. Messerle. 1999. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329.
8. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus, p. 2493-2523. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
9. Brown, J. M., H. Kaneshima, and E. S. Mocarski. 1995. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J. Infect. Dis. 171:1599-1603.
10. Cha, T.-A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
11. Chambers, J., A. Angulo, D. Amaratunga, H. Guo, Y. Jiang, J. S. Wan, A. Bittner, K. Frueh, M. R. Jackson, P. A. Peterson, M. G. Erlander, and P. Ghazal. 1999. DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 73:5757-5766.
12. DiLoreto, D., Jr., L. G. Epstein, E. S. Lazar, W. J. Britt, and M. del Cerro. 1994. Cytomegalovirus infection of human retinal tissue: an in vivo model. Lab. Investig. 71:141-148.
13. Dunn, W., C. Chou, H. Li, R. Hai, D. Patterson, V. Stolc, H. Zhu, and F. Liu. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA 100:14223-14228.
14. Elek, S. D., and H. Stern. 1974. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet i:1-5.
15. Fleisher, G. R., S. E. Starr, H. M. Friedman, and S. A. Plotkin. 1982. Vaccination of pediatric nurses with live attenuated cytomegalovirus. Am. J. Dis. Child. 136:294-296.
16. Jamieson, B. D., G. M. Aldrovandi, and J. A. Zack. 1996. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Semin. Immunol. 8:215-221.
17. Jones, T. R., and V. P. Muzithras. 1992. A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family. J. Virol. 66:2541-2546.
18. Just, M., A. Buergin-Wolff, G. Emoedi, and R. Hernandez. 1975. Immunisation trials with live attenuated cytomegalovirus TOWNE 125. Infection 3:111-114.
19. Kern, E. R., R. J. Rybak, C. B. Hartline, and D. J. Bidanset. 2001. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections. Antivir. Chem. Chemother. 12:149-156.
20. Marchini, A., H. Liu, and H. Zhu. 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:1870-1878.
21. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Shultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
22. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, and U. H. Koszinowski. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA 94:14759-14763.
23. Mocarski, E. S., M. Bonyhadi, S. Salimi, J. M. McCune, and H. Kaneshima. 1993. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc. Natl. Acad. Sci. USA 90:104-108.
24. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
25. Moffat, J. F., L. Zerboni, P. R. Kinchington, C. Grose, H. Kaneshima, and A. M. Arvin. 1998. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:965-974.
26. Murphy, E., D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M. A. Jarvis, G. Hahn, J. A. Nelson, R. M. Myers, and T. E. Shenk. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 100:14976-14981.
27. Pass, R. F. 2001. Cytomegalovirus, p. 2675-2705. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
28. Penfold, M. E., D. J. Dairaghi, G. M. Duke, N. Saederup, E. S. Mocarski, G. W. Kemble, and T. J. Schall. 1999. Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA 96:9839-9844.
29. Plotkin, S. A., J. Farquhar, and E. Horberger. 1976. Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J. Infect. Dis. 134:470-475.
30. Plotkin, S. A., T. Furukawa, N. Zygraich, and C. Huygelen. 1975. Candidate cytomegalovirus strain for human vaccination. Infect. Immun. 12:521-527.
31. Plotkin, S. A., and E. S. Huang. 1985. Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J. Infect. Dis. 152:395-397.
32. Plotkin, S. A., S. E. Starr, H. M. Friedman, E. Gonczol, and R. E. Weibel. 1989. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J. Infect. Dis. 159:860-865.
33. Prichard, M. N., M. E. Penfold, G. M. Duke, R. R. Spaete, and G. W. Kemble. 2001. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 11:191-200.
34. Quinnan, G. V., Jr., M. Delery, A. H. Rook, W. R. Frederick, J. S. Epstein, J. F. Manischewitz, L. Jackson, K. M. Ramsey, K. Mittal, S. A. Plotkin, et al. 1984. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann. Intern. Med. 101:478-483.
35. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
36. Soderberg-Naucler, C., and J. Y. Nelson. 1999. Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system. Intervirology 42:314-321.
37. Staczek, J. 1990. Animal cytomegaloviruses. Microbiol. Rev. 54:247-265.
38. Swaminathan, S., H. M. Ellis, L. S. Waters, D. Yu, E. C. Lee, D. L. Court, and S. K. Sharan. 2001. Rapid engineering of bacterial artificial chromosomes using oligonucleotides. Genesis 29:14-21.
39. Ulger, C., G. A. Toruner, M. Alkan, M. Mohammed, S. Damani, J. Kang, A. Galante, H. Aviv, P. Soteropoulos, P. P. Tolias, M. N. Schwalb, and J. J. Dermody. 2003. Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line. Cancer Genet. Cytogenet. 147:28-35.
40. Valsamakis, A., P. G. Auwaerter, B. K. Rima, H. Kaneshima, and D. E. Griffin. 1999. Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue. J. Virol. 73:8791-8797.
41. Wang, W., C. E. Patterson, S. Yang, and H. Zhu. 2004. Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones. J. Virol. Methods 121:137-143.
42. Yu, D., H. M. Ellis, E. C. Lee, N. A. Jenkins, N. G. Copeland, and D. L. Court. 2000. An efficient recombination system for chromosome engineering in Escherichia coli. Proc. Natl. Acad. Sci. USA 97:5978-5983.
43. Yu, D., M. C. Silva, and T. Shenk. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. USA 100:12396-12401.
44. Yu, D., G. A. Smith, L. W. Enquist, and T. Shenk. 2002. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76:2316-2328.